Clinical Trial Update: Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery [Phase 1, Phase 2]

View source ↗

Summary

A planned Phase 1/Phase 2 trial combines stereotactic body radiotherapy with immunotherapy for patients with early-stage non-small cell lung cancer who are sche…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: NSCLC, Stage I | Phase 1, Phase 2 | Status: UNKNOWN